DYSTROPHIC EPIDERMOLYSIS BULLOSA
Clinical trials for DYSTROPHIC EPIDERMOLYSIS BULLOSA explained in plain language.
Never miss a new study
Get alerted when new DYSTROPHIC EPIDERMOLYSIS BULLOSA trials appear
Sign up with your email to follow new studies for DYSTROPHIC EPIDERMOLYSIS BULLOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to heal wounds in rare skin disease
Disease control Recruiting nowThis study tests whether adding IV IgG treatment to standard VYJUVEK therapy can help wounds heal faster and reduce blistering in people with a severe form of epidermolysis bullosa (RDEB). The treatment targets antibodies that may interfere with healing. Eight participants will b…
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE1, PHASE2 • Sponsor: M. Peter Marinkovich • Aim: Disease control
Last updated May 26, 2026 06:57 UTC
-
New gel may heal blistering skin disease wounds
Disease control Recruiting nowThis study tests a new topical gel (EV.FV) to help heal wounds in people with a rare, painful skin condition called epidermolysis bullosa (EB). The gel uses tiny particles from cells to promote skin repair. About 20 participants with active wounds will receive the treatment to se…
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE1, PHASE2 • Sponsor: Isfahan University of Medical Sciences • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New eye drop aims to stop painful corneal scratches in rare skin disease
Disease control Recruiting nowThis study tests an eye drop called KB803 in 16 people aged 6 months and older with dystrophic epidermolysis bullosa (DEB), a rare genetic condition causing fragile skin and recurrent corneal abrasions. The trial compares KB803 to a placebo to see if it safely reduces the number …
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE3 • Sponsor: Krystal Biotech, Inc. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New gel could ease pain and heal wounds in butterfly skin disease
Symptom relief Recruiting nowThis study tests a gel called TCP-25 on open wounds in people with epidermolysis bullosa (EB), a condition that causes fragile, blistering skin. About 32 participants aged 4 and older will have two matching wounds treated—one with the study gel and one with a placebo—to see if th…
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE2 • Sponsor: Xinnate AB • Aim: Symptom relief
Last updated May 26, 2026 04:37 UTC